SMAD3 and renal fibrosis: In this context, naringenin treatment in mice with obstructive nephropathy attenuated renal fibrosis by inhibiting the expression and activation of smad3, a crucial pro-fibrotic factor, leading to a reduction in collagen I and α-SMA in renal tissue.